<DOC>
	<DOCNO>NCT01603433</DOCNO>
	<brief_summary>This single center , prospective , non-randomized , feasibility study evaluation safety , efficacy performance Sapheon™ Closure System treatment incompetent saphenous vein .</brief_summary>
	<brief_title>The Sapheon Closure System Feasibility Study</brief_title>
	<detailed_description>Venous insufficiency low extremity common condition influence genetic mechanical factor , chronic progressive disorder . The primary objective clinical Study 1. demonstrate safety Sapheon™ Closure System treatment incompetent saphenous vein , 2. demonstrate early late efficacy The Sapheon™ Closure System treatment incompetent saphenous vein , 3. demonstrate satisfactory performance Sapheon™ Closure System device component .</detailed_description>
	<mesh_term>Venous Insufficiency</mesh_term>
	<criteria>Males nonpregnant female ≥21 year age &lt; 76 year age . Venous reflux disease GSV diagnose clinical symptom , without visible varicosity , confirm duplex ultrasound image . Candidate surgical closure segment GSV . CEAP classification C2 , C3 C4 . Ability walk unassisted . Life expectancy least 18 month . Weight &gt; 110 lb . ( 50 kg ) . Ability attend followup visit . Ability understand investigational nature treatment , provide write informed consent . Previous surgical procedure ( surgical , thermal , chemical ablation ) associate venous segment treat . Diameter index vein ( Supine ) &lt; 3mm &gt; 12 mm segment . Tortuous GSV , opinion Investigator limit catheter placement . Local systemic infection . Insulin dependent diabetes . Leg obesity impair ability gain access treatment leg , and/or apply sufficient compression treatment . Documented history superficial deep thrombophlebitis . Varicosities secondary pelvic abdominal tumor . Significant arterial insufficiency ; demonstrate absence ankle pulse . Known sensitivity cyanoacrylate ( CA ) adhesive positive reaction prior surgery ( inject small peripheral vein agent ) . The Study surgeon judge need injection subject 's reaction injection clinical ground . Formal duplication saphenous trunk index vein ( Accessory GSV segment allow ) . Hypercoaguable state . Presence incompetent perforators treatment length . History right ventricular failure . Significant femoral popliteal vein insufficiency . BMI &gt; 35 Additional procedure treatment leg likely require within six month investigational procedure . Current participation another clinical study involve investigational agent treatment , within 30 day prior enrollment . Other concurrent medical condition ( chronic acute nature ) opinion Investigator may prevent safe participation otherwise render subject ineligible Study .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>76 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>